Category: biotech

.Monopar Therapies is actually recovering a medication coming from the dump of AstraZeneca’s rare disease pipeline. It has licensed ALXN-1840, an applicant for the therapy

.AN2 Rehabs is actually reassessing its own service in response to dull midphase data, pledging to give up half its own employees and also stop

.ALX Oncology’s phase 2 stomach cancer cells action price has actually diminished. After seeing its own CD47 blocker conveniently hammered command over the very first

.After much more than twenty years of work on neurodegenerative diseases, Swiss biotech AC Invulnerable insurance claims it could have a game changer on its